Soreijia Fama

4597.TTSE GROWTHPharmaceutical

Filed as Solasia Pharma K.K. (2022-08–2026-08)

Key numbers · FY ended 2025-12

Revenue¥429m+35.8% YoY Operating income−¥861m—Net income (owners)−¥876m—Total assets¥2.1bn+57.5% YoY EPS (basic)¥-3.69+62.2% YoY

Full financial history and reports →

Stock price4597 · View chart ↗

Open the price chart on TradingView.

Latest filings

Wed, Aug 6 · JST1 filing

15:365% STAKESoreijia Fama · Macquarie Bank Limited · 11.62% → 9.73%−1.89pp

Wed, Jul 23 · JST1 filing

15:515% STAKESoreijia Fama · Macquarie Bank Limited · 12.64% → 11.62%−1.02pp

Fri, Jul 11 · JST1 filing

15:315% STAKESoreijia Fama · Macquarie Bank Limited · 13.73% → 12.64%−1.09pp

Thu, Jul 10 · JST1 filing

15:485% STAKESoreijia Fama · Macquarie Bank Limited · 15.12% → 13.73%−1.39pp

Fri, Jul 4 · JST1 filing

15:515% STAKESoreijia Fama · Macquarie Bank Limited · 13.83% → 15.12%+1.29pp

All filings →

Major holders (5%+) · 1

Holder	Stake	Change	Filed
Macquarie Bank Limited	9.73%	-1.89pp	2025-08-06

Each holder's own ratio from its most recent large-shareholding report.